Brian O. Newman's most recent trade in Colgate-Palmolive Co. was a trade of 208 Common Stock done at an average price of $89.9 . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Colgate-Palmolive | Brian O. Newman | Director | Grant, award, or other acquisition of securities at price $ 89.91 per share. | 01 Jul 2025 | 208 | 4,830 (0%) | 0% | 89.9 | 18,701 | Common Stock |
| CVS Health | Brian O. Newman | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2025 | 94,786 | 94,786 | - | - | Stock Option | |
| CVS Health | Brian O. Newman | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 64.04 per share. | 31 May 2025 | 21,861 | 21,861 | - | 64.0 | 1,399,978 | Common Stock (RSUs) |
| Colgate-Palmolive | Brian O. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 2,272 | 2,272 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive | Brian O. Newman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2025 | 2,019 | 4,621 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive | Brian O. Newman | Director | Grant, award, or other acquisition of securities at price $ 91.99 per share. | 01 Apr 2025 | 203 | 2,597 (0%) | 0% | 92.0 | 18,674 | Common Stock |
| Colgate-Palmolive | Brian Newman O. | Director | Grant, award, or other acquisition of securities at price $ 93.18 per share. | 02 Jan 2025 | 201 | 2,388 (0%) | 0% | 93.2 | 18,729 | Common Stock |